Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
4.430
-0.290 (-6.14%)
At close: Nov 20, 2024, 4:00 PM
4.300
-0.130 (-2.93%)
Pre-market: Nov 21, 2024, 7:00 AM EST
Acelyrin Employees
Acelyrin had 135 employees as of December 31, 2023. The number of employees increased by 88 or 187.23% compared to the previous year.
Employees
135
Change (1Y)
88
Growth (1Y)
187.23%
Revenue / Employee
n/a
Profits / Employee
-$1,958,556
Market Cap
444.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 135 | 88 | 187.23% |
| Dec 31, 2022 | 47 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Health Catalyst | 1,300 |
| Pacific Biosciences of California | 796 |
| National Research | 435 |
| MeiraGTx Holdings | 425 |
| Xeris Biopharma Holdings | 377 |
| Arcturus Therapeutics Holdings | 180 |
| Tango Therapeutics | 140 |
| Korro Bio | 102 |
SLRN News
- 7 days ago - Acelyrin, Inc. (SLRN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 14 days ago - ACELYRIN, INC. to Report Third Quarter 2024 Financial Results and Corporate Update on November 13, 2024 - GlobeNewsWire
- 2 months ago - Acelyrin: Straight Move To Phase 3 TED Studies Makes It Must Watch - Seeking Alpha
- 2 months ago - ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024 - GlobeNewsWire
- 3 months ago - ACELYRIN, INC. to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Acelyrin Cuts Workforce, Deprioritizes Former Lead Drug Izokibep - Benzinga
- 3 months ago - Acelyrin, Inc. (SLRN) Q2 2024 Earnings Call Transcript - Seeking Alpha